<SEC-DOCUMENT>0001193125-23-241316.txt : 20230925
<SEC-HEADER>0001193125-23-241316.hdr.sgml : 20230925
<ACCEPTANCE-DATETIME>20230925160202
ACCESSION NUMBER:		0001193125-23-241316
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20230919
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230925
DATE AS OF CHANGE:		20230925

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Aeglea BioTherapeutics, Inc.
		CENTRAL INDEX KEY:			0001636282
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				464312787
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37722
		FILM NUMBER:		231275841

	BUSINESS ADDRESS:	
		STREET 1:		221 CRESCENT STREET
		STREET 2:		BUILDING 17, SUITE 102B
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02453
		BUSINESS PHONE:		6176515940

	MAIL ADDRESS:	
		STREET 1:		221 CRESCENT STREET
		STREET 2:		BUILDING 17, SUITE 102B
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02453
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d519116d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:agle="http://aegleabio.com/20230919" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_SecurityExchangeName" name="dei:SecurityExchangeName" contextRef="duration_2023-09-19_to_2023-09-19">NASDAQ</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2023-09-19_to_2023-09-19">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2023-09-19_to_2023-09-19">0001636282</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="agle-20230919.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2023-09-19_to_2023-09-19"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001636282</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-09-19</xbrli:startDate> <xbrli:endDate>2023-09-19</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">WASHINGTON, D.C. 20549</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2023-09-19_to_2023-09-19">8-K</ix:nonNumeric></span></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2023-09-19_to_2023-09-19" format="ixt:datemonthdayyearen">September&#160;19, 2023</ix:nonNumeric></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2023-09-19_to_2023-09-19">AEGLEA BIOTHERAPEUTICS, INC.</ix:nonNumeric> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of Registrant as Specified in Its Charter)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2023-09-19_to_2023-09-19" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2023-09-19_to_2023-09-19">001-37722</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2023-09-19_to_2023-09-19">46-4312787</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or Other Jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of Incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2023-09-19_to_2023-09-19">221 Crescent Street</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="duration_2023-09-19_to_2023-09-19">Building 23</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine3" contextRef="duration_2023-09-19_to_2023-09-19">Suite 105</ix:nonNumeric></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2023-09-19_to_2023-09-19">Waltham</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2023-09-19_to_2023-09-19" format="ixt-sec:stateprovnameen">Massachusetts</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2023-09-19_to_2023-09-19">02453</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of Principal Executive Offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s Telephone Number, Including Area <span style="white-space:nowrap">Code:&#160;<ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2023-09-19_to_2023-09-19">617</ix:nonNumeric>&#160;<ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2023-09-19_to_2023-09-19">651-5940</ix:nonNumeric></span></p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former Name or Former Address, if Changed Since Last Report)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2023-09-19_to_2023-09-19" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2023-09-19_to_2023-09-19" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2023-09-19_to_2023-09-19" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2023-09-19_to_2023-09-19" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center"><br />Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2023-09-19_to_2023-09-19">Common Stock, $0.0001 Par Value Per Share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2023-09-19_to_2023-09-19">AGLE</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <span style=" -sec-ix-hidden:Hidden_dei_SecurityExchangeName">The Nasdaq Capital Market</span> </td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#160;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 (&#167; <span style="white-space:nowrap">240.12b-2</span> of this chapter).</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&#8194;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2023-09-19_to_2023-09-19" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#8194;&#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;1.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Entry into a Material Definitive Agreement. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Biologics Master Services Agreement &#8212; WuXi Biologics (Hong Kong) Limited </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In April 2023, Paragon Therapeutics, Inc. (&#8220;Paragon&#8221;) and WuXi Biologics (Hong Kong) Limited (&#8220;WuXi Biologics&#8221;) entered into a biologics master services agreement (the &#8220;WuXi Biologics MSA&#8221;), which was subsequently novated to Aeglea BioTherapeutics, Inc. (the &#8220;Company&#8221;) by Paragon on September&#160;19, 2023 pursuant to a novation agreement (the &#8220;Novation Agreement&#8221;) among the Company, Paragon and Wuxi Biologics. The WuXi Biologics MSA governs certain development activities and GMP manufacturing and testing for the Company&#8217;s SPY001 program, as well as potential future programs, on a work order basis. Under the WuXi Biologics MSA, the Company is obligated to pay WuXi Biologics a service fee and all <span style="white-space:nowrap">non-cancellable</span> obligations in the amount specified in each work order associated with the agreement for the provision of services. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The WuXi Biologics MSA terminates on the later of&#8201; (i)&#160;June&#160;20, 2027 or (ii)&#160;the completion of services under all work orders executed by the parties prior to June&#160;20, 2027, unless terminated earlier. The term of each work order terminates upon completion of the services under such work order, unless terminated earlier. The Company can terminate the WuXi Biologics MSA or any work order at any time upon 30 days&#8217; prior written notice and immediately upon written notice if WuXi Biologics fails to obtain or maintain required material governmental licenses or approvals. Either party may terminate a work order (i)&#160;at any time upon six months&#8217; prior notice with reasonable cause, provided however that if WuXi Biologics terminates a work order in such manner, no termination or cancellation fees shall be paid by the Company and (ii)&#160;immediately for cause upon (a)&#160;the other party&#8217;s material breach that remains uncured for 30 days after notice of such breach, (b)&#160;the other party&#8217;s bankruptcy or (c)&#160;a force majeure event that prevents performance for a period of at least 90 days. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Cell Line License Agreement &#8212; WuXi Biologics (Hong Kong) Limited </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In April 2023, Paragon and WuXi Biologics entered into a cell line license agreement (the &#8220;Cell Line License Agreement&#8221;), which was subsequently novated to the Company by Paragon pursuant to the Novation Agreement. Under the Cell Line License Agreement, the Company received a <span style="white-space:nowrap">non-exclusive,</span> worldwide, sublicensable license to certain of WuXi Biologics&#8217;s <span style="white-space:nowrap">know-how,</span> cell line, biological materials (the &#8220;WuXi Biologics Licensed Technology&#8221;) and media and feeds to make, have made, use, sell and import certain therapeutic products produced through the use of the cell line licensed by WuXi Biologics under the Cell Line License Agreement (the &#8220;WuXi Biologics Licensed Products&#8221;). Specifically, the WuXi Biologics Licensed Technology is used in certain manufacturing activities in support of the SPY001 program. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In consideration for the license, the Company agreed to pay WuXi Biologics a <span style="white-space:nowrap">non-refundable</span> license fee of&#8201; $150,000. Additionally, if the Company manufactures all of its commercial supplies of bulk drug product with a manufacturer other than WuXi Biologics or its affiliates, the Company is required to make royalty payments to WuXi Biologics in an amount equal to a fraction of a single digit percentage of global net sales of WuXi Biologics Licensed Products manufactured by a third-party manufacturer (the &#8220;Royalty&#8221;). If the Company manufactures part of its commercial supplies of the WuXi Biologics Licensed Products with WuXi Biologics or its affiliates, then the Royalty will be reduced accordingly on a pro rata basis. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Cell Line License Agreement will continue indefinitely unless terminated (i)&#160;by the Company upon six months&#8217; prior written notice and the Company&#8217;s payment of all undisputed amounts due to WuXi Biologics through the effective date of termination, (ii)&#160;by WuXi Biologics for a material breach by the Company that remains uncured for 60 days after written notice, (iii)&#160;by WuXi Biologics if the Company fails to make a payment and such failure continues for 30 days after receiving notice of such failure, or (iv)&#160;by either party upon the other party&#8217;s bankruptcy. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;3.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On September 22, 2023, the Company received a letter (the &#8220;Compliance Letter&#8221;) from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;) notifying the Company that it had regained compliance with the $1.00 per share minimum bid price requirement for continued inclusion on the Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the &#8220;Minimum Bid Price Requirement&#8221;). </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Compliance Letter noted that (1) the Company&#8217;s common stock, par value $0.0001 per share (the &#8220;Common Stock&#8221;), had a closing bid price of at least $1.00 per share for a minimum of ten consecutive business days from September 8, 2023 to September 21, 2023, (2) the Company has regained compliance with the Minimum Bid Price Requirement, and (3) Nasdaq considers the matter closed. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In order to regain compliance with the Minimum Bid Price Requirement during an additional 180-calendar day grace period, the Company implemented a reverse stock split (the &#8220;Reverse Stock Split&#8221;) of the Company&#8217;s Common Stock, at a ratio of 1-for-25 and a reduction in the total number of authorized shares of Common Stock from 500,000,000 shares to 20,000,000 shares, each with an effective time of 12:01 a.m. Eastern Time on September 8, 2023 (the &#8220;Effective Time&#8221;). The Reverse Stock Split was approved by the Company&#8217;s stockholders on June&#160;6, 2023 at the Company&#8217;s 2023 Annual Meeting of Stockholders, and came into effect as of the Effective Time. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;5.02</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On September 5, 2023, the Company filed a Current Report on Form 8-K (the &#8220;Report&#8221;) to disclose that, effective September 1, 2023, Scott Burrows succeeded Jonathan Alspaugh as the Company&#8217;s Chief Financial Officer. The Report also disclosed the expected transition of Mr. Alspaugh into a strategic advisory consulting role at the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On September 22, 2023, Mr. Alspaugh and the Company entered into a Separation and Consulting Agreement and General Release of Claims (the&#160;&#8220;Separation Agreement&#8221;). The Separation Agreement provides for the following severance payments and benefits to Mr.&#160;Alspaugh, as consideration for his general release of claims in favor of the Company: (i) aggregate severance payments of $623,000 payable in installments over 12 months, (ii) fully subsidized COBRA coverage for up to 12&#160;months, (iii)&#160;a retention bonus of $168,247, payable in a lump sum, (iv)&#160;accelerated vesting of all stock options that were scheduled to vest during the 12-month period following the last day on which Mr.&#160;Alspaugh provides consulting services to the Company, (v) extension of the post-termination exercise period of outstanding stock options to six months, and (vi) potential transaction bonuses in the event the Company consummates any sale, licensing, disposition or monetization transaction relating to pegtarviliase or any of the Company&#8217;s legacy development-stage assets prior to June 23, 2024. The Separation Agreement provides that Mr. Alspaugh will provide consulting services to the Company through February 29, 2024 (which consulting period may be extended by mutual agreement of the parties or may be earlier terminated by Mr. Alspaugh, by the Company for cause or as a result of Mr. Alspaugh&#8217;s death or disability). During the consulting period, Mr. Alspaugh will receive a consulting fee of $500 per hour and will continue to vest in any outstanding stock options. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing description of the Separation Agreement is not complete and is qualified in its entirety by reference to the Separation Agreement, which is filed herewith as Exhibit 10.1 and incorporated by reference herein. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;9.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">(d)&#160;Exhibits</span> </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:5%"></td>
<td style="width:92%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit<br />Number</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d519116dex101.htm">Separation and Consulting Agreement and General Release of Claims by and between the Company and Jonathan Alspaugh, dated as of September 22, 2023. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document).</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:45%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:3%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:45%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3"><span style="font-weight:bold">AEGLEA BIOTHERAPEUTICS, INC.</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date: September&#160;25, 2023</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Cameron Turtle</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Cameron Turtle</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Chief Operating Officer</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>d519116dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SEPARATION AND CONSULTING AGREEMENT </U></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>AND GENERAL RELEASE OF CLAIMS </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This SEPARATION AND CONSULTING AGREEMENT AND GENERAL RELEASE OF CLAIMS (this &#147;<U>Agreement</U>&#148;) is entered into by and between
Aeglea BioTherapeutics, Inc., a Delaware corporation (the &#147;<U>Company</U>&#148;), and Jonathan Alspaugh (&#147;<U>Executive</U>&#148;). Executive and the Company are each referred to herein as a &#147;<U>Party</U>&#148; and collectively as the
&#147;<U>Parties</U>.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, Executive&#146;s employment with the Company terminated effective as of September&nbsp;1,
2023 (the &#147;<U>Separation Date</U>&#148;); and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, as of the Separation Date, Executive holds the outstanding equity
awards set forth on <U>Exhibit A</U> hereto (collectively the &#147;<U>Options</U>&#148;), in each case, pursuant to those certain Notices of Stock Option Grants and Stock Option Agreements under the Aeglea BioTherapeutics, Inc. 2016 Equity
Incentive Plan (collectively, the &#147;<U>Award Agreements</U>&#148;) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, reference is made to that certain Employee
Invention Assignment, Confidentiality and <FONT STYLE="white-space:nowrap">Non-Competition</FONT> Agreement between Executive and the Company (the &#147;<U>EIACN Agreement</U>&#148;) and to that certain Severance Agreement between Executive and the
Company dated July&nbsp;6, 2021 (the &#147;<U>Severance Agreement</U>&#148;); and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, the Company wishes to provide Executive
with certain severance payments and benefits, which are conditioned upon Executive&#146;s execution, delivery, <FONT STYLE="white-space:nowrap">non-revocation</FONT> of and compliance with this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>NOW, THEREFORE</B>, in consideration of the promises set forth herein, and for other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged by Executive and the Company, the Parties hereby agree as follows: </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>1.&#8195;<U></U></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>Separation from Employment</U>. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&#8195;The Company and Executive acknowledge and agree that Executive&#146;s employment with the Company will end as of the Separation Date.
As of the Separation Date, Executive will no longer be employed by the Company or any other Company Party (as defined below), and Executive will be deemed to have automatically resigned (i)&nbsp;as an officer of the Company and its affiliates (as
applicable) and (ii)&nbsp;from the board of managers, board of directors or similar governing body of each of the Company and its affiliates (as applicable) and any other corporation, limited liability company, trade organization, or other entity in
which the Company or any of its affiliates holds an equity interest or with respect to which board or similar governing body Executive serves as the designee or other representative of the Company or any of its affiliates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&#8195;Executive acknowledges and agrees that Executive has been paid in full all bonuses, been provided all benefits, and otherwise
received all wages, compensation and other sums that Executive has been owed by each Company Party. Executive further acknowledges and agrees that Executive has received all vacation and leaves (paid and unpaid), including payment of accrued but
unpaid paid time off, that Executive has been entitled to receive from each Company Party. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2.</B>&#8194;&#8201;&#8195;<B><U>Separation Payments and Benefits</U></B>. Provided that Executive:
(x)&nbsp;executes this Agreement and returns a copy of this Agreement that has been executed by Executive to the Company so that it is received by Cameron Turtle, Chief Operating Officer, 221 Crescent Street, Built 17, Suite 102B, Waltham, MA 02453
(email: ) no later than 5:00 pm CT on September&nbsp;22, 2023; (y) does not revoke this Agreement during the Release Revocation Period (as defined below); and (z)&nbsp;remains in compliance with the other terms and conditions set forth in this
Agreement (including under Section&nbsp;5), Executive shall receive the following separation payments and benefits: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&#8195;the Company
shall pay to Executive aggregate severance payments of $623,000 (the &#147;<U>Severance Amount</U>&#148;), which Severance Amount shall be paid through salary continuation in equal installments in accordance with the Company&#146;s standard payroll
procedures, with the initial payment to occur on the first payroll date following the 60<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> day following the Separation Date, with the first installment to include a catchup payment for amounts
covering the period from the date of Separation Date through the first payment date; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&#8195;if Executive timely elects continued
coverage under the Consolidated Omnibus Budget Reconciliation Act (&#147;<B><I>COBRA</I></B>&#148;), the Company shall pay the full amount of Executive&#146;s COBRA premiums on behalf of the Executive for the Executive&#146;s continued coverage
under the Company&#146;s health, dental and vision plans, including coverage for the Executive&#146;s eligible dependents, for the Severance Period (as defined in the Severance Agreement); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&#8195;the Company shall pay to Executive a lump sum payment of $168,246.58 (the &#147;<U>Retention Bonus</U>&#148;) in accordance with the
terms of that certain Incentive Agreement between Executive and the Company dated June&nbsp;21, 2023 (the &#147;<U>Incentive Agreement</U>&#148;), which Retention Bonus shall be paid following the expiration of the Release Revocation Period but in
no event later than December&nbsp;31, 2023; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&#8195;effective as of the last day of the Consulting Period, all unvested Options
scheduled to vest within the <FONT STYLE="white-space:nowrap">12-month</FONT> period following the last day of the Consulting Period shall immediately become fully vested and exercisable; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)&#8195;all vested Options (after giving effect to Section&nbsp;2(d) and Section&nbsp;5(c)) will remain outstanding for six months following
the last day of the Consulting Period and may be exercised during such period in accordance with the terms of the Award Agreements; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f)&#8195;in the event that any sale, licensing, disposition, or monetization transaction or multiple transactions relating to pegtarviliase
or any of the Company&#146;s legacy development-stage assets is consummated prior to June&nbsp;23, 2024, then, and only then, the Company will pay to Executive a cash bonus equal to: (i) 1.0% of the value of the upfront consideration received by the
Company in such transactions, plus (ii) 0.5% of the risk-adjusted net present value of the contingent consideration payable to the Company in such transactions, in each case, to be paid within 30 days of the end of the calendar quarter in which such
transaction is consummated, in each case, in accordance the parameters established by the Compensation Committee of the Board of Directors of the Company on August&nbsp;1, 2023. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Executive acknowledges and agrees that the consideration referenced in this Section&nbsp;2 represents the
entirety of the amounts Executive is eligible to receive as severance pay and benefits from the Company or any other Company Party pursuant to the Severance Agreement and otherwise. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>3.&#8195;<U></U></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>Release of Liability for Claims</U>. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&#8195;For good and valuable consideration set forth in this Agreement, including the consideration set forth in
<U>Section</U><U></U><U>&nbsp;2</U>, Executive knowingly and voluntarily (for Executive, Executive&#146;s family, and Executive&#146;s heirs, executors, administrators and assigns) hereby releases and forever discharges the Company and its
affiliates, predecessors, successors, subsidiaries and benefit plans, and the foregoing entities&#146; respective equity-holders, officers, directors, managers, members, partners, employees, agents, representatives, and other affiliated persons, and
the Company&#146;s and its affiliates&#146; benefit plans (and the fiduciaries and trustees of such plans) (collectively, the &#147;<U>Company Parties</U>&#148;), from liability for, and Executive hereby waives, any and all claims, damages, or
causes of action of any kind related to Executive&#146;s ownership of any interest in any Company Party, Executive&#146;s employment with any Company Party, the termination of such employment, and any other acts or omissions related to any matter
occurring on or prior to the date that Executive executes this Agreement, including (i)&nbsp;any alleged violation through such time of: (A)&nbsp;any federal, state or local anti-discrimination or anti-retaliation law, regulation or ordinance,
including the Age Discrimination in Employment Act of 1967 (including as amended by the Older Workers Benefit Protection Act), Title VII of the Civil Rights Act of 1964, the Civil Rights Act of 1991, Sections 1981 through 1988 of Title 42 of the
United States Code and the Americans with Disabilities Act of 1990; (B) the Employee Retirement Income Security Act of 1974 (&#147;<U>ERISA</U>&#148;); (C) the Immigration Reform Control Act; (D)&nbsp;the National Labor Relations Act; (E)&nbsp;the
Occupational Safety and Health Act; (F)&nbsp;the Family and Medical Leave Act of 1993; (G) the Texas Labor Code (specifically including the Texas Payday Law, the Texas Anti-Retaliation Act, Chapter 21 of the Texas Labor Code, and the Texas
Whistleblower Act); (H) any federal, state or local wage and hour law; (I)&nbsp;any other local, state or federal law, regulation or ordinance; or (J)&nbsp;any public policy, contract, tort, or common law claim; (ii)&nbsp;any allegation for costs,
fees, or other expenses including attorneys&#146; fees incurred in or with respect to a Released Claim; (iii)&nbsp;any and all rights, benefits or claims Executive may have under any employment contract, incentive compensation plan or equity-based
plan with any Company Party or to any ownership interest in any Company Party (other than any rights under the Award Agreements), including any claims relating to an alleged change in control or potential change in control occurring prior to the
Separation Date ; and (iv)&nbsp;any claim for compensation or benefits of any kind not expressly set forth in this Agreement (collectively, the &#147;<U>Released Claims</U>&#148;). This Agreement is not intended to indicate that any such claims
exist or that, if they do exist, they are meritorious. Rather, Executive is simply agreeing that, in exchange for any consideration received by Executive pursuant to <U>Section</U><U></U><U>&nbsp;2</U>, any and all potential claims of this nature
that Executive may have against any of the Company Parties, regardless of whether they actually exist, are expressly settled, compromised and waived. <B>THIS RELEASE INCLUDES MATTERS ATTRIBUTABLE TO THE SOLE OR PARTIAL NEGLIGENCE (WHETHER GROSS OR
SIMPLE) OR OTHER FAULT, INCLUDING STRICT LIABILITY, OF ANY OF THE COMPANY PARTIES.</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&#8195;In no event shall the Released Claims
include (i)&nbsp;any claim that arises after the date that Executive signs this Agreement; (ii)&nbsp;any claim to vested benefits under an employee benefit plan that is subject to ERISA, unemployment benefits, or worker&#146;s compensation; and
(iii)&nbsp;any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
claim for breach of, or otherwise arising out of, this Agreement. Further notwithstanding this release of liability, nothing in this Agreement prevents Executive from filing any <FONT
STYLE="white-space:nowrap">non-legally</FONT> waivable claim (including a challenge to the validity of this Agreement) with the Equal Employment Opportunity Commission (&#147;<U>EEOC</U>&#148;) or comparable state or local agency or participating in
any investigation or proceeding conducted by the EEOC or comparable state or local agency or cooperating in any such investigation or proceeding; however, Executive understands and agrees that Executive is waiving any and all rights to recover any
monetary or personal relief from a Company Party as a result of such EEOC or comparable state or local agency or proceeding or subsequent legal actions. Further, nothing in this Agreement prohibits or restricts Executive from filing a charge or
complaint with, or cooperating in any investigation with, the Securities and Exchange Commission, the Financial Industry Regulatory Authority, or any other governmental agency, entity or authority (each, a &#147;<U>Government Agency</U>&#148;). This
Agreement does not limit Executive&#146;s right to receive an award for information provided to a Government Agency. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>4.</B>&#8194;&#8201;&#8195;<B><U>Representations and Warranties Regarding Claims</U></B>. Executive represents and warrants that, as of the time at which
Executive signs this Agreement, Executive has not filed or joined any claims, complaints, charges, or lawsuits against any of the Company Parties with any governmental agency or with any state or federal court or arbitrator for, or with respect to,
a matter, claim, or incident that occurred or arose out of one or more occurrences that took place on or prior to the time at which Executive signs this Agreement. Executive further represents and warrants that Executive has not made any assignment,
sale, delivery, transfer or conveyance of any rights Executive has asserted or may have against any of the Company Parties with respect to any Released Claim. Executive represents and warrants that, as of the time at which Executive signs this
Agreement, Executive is not aware of any facts that may lead to a worker&#146;s compensation claim. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.&#8195;<U></U></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>Consulting Services</U>. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&#8195;Beginning on the Separation Date through February&nbsp;29, 2024 (such period, as may be extended or earlier terminated as provided in
<U>Section</U><U></U><U>&nbsp;5(e)</U>, the &#147;<U>Consulting Period</U>&#148;), the Company and Executive agree that Executive shall serve as a consultant to the Company providing the Services (as defined below) for no more than 80 hours per
month unless otherwise approved in writing. During the Consulting Period, Executive agrees to provide transition and advisory services, as may be requested from time to time by any officer or member of the Board of Directors of the Company (the
&#147;<U>Services</U>&#148;). Executive must submit to the Company a written statement detailing Executive&#146;s time incurred in performing the Services (each, a &#147;<U>Written Statement</U>&#148;) within 15 days following the end of each
calendar month. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&#8195;During the Consulting Period, Executive shall receive a consulting fee of $500 per hour, payable within 30 days
following receipt by the Company of a Written Statement. As an independent contractor, no income or other taxes shall be withheld from the amounts paid to Executive pursuant to this <U>Section</U><U></U><U>&nbsp;5(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&#8195;During the Consulting Period, Executive will continue to vest in the Options in accordance with the terms of the Award Agreements.
For the avoidance of doubt, all unvested Option (after giving effect to <U>Section</U><U></U><U>&nbsp;2(d)</U>) will be automatically forfeited upon termination of the Consulting Period. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&#8195;During the Consulting Period, Executive&#146;s relationship with the Company shall
be that of an independent contractor. Executive shall control and determine how the Services are to be accomplished; provided, however, that in all events Executive shall perform the Services in a quality, workmanlike manner and within reasonable
deadlines established by the Company and consistent with the professional talent of Executive that Executive applied during Executive&#146;s prior service with the Company. As an independent contractor, Executive shall not participate as an active
employee in any employee benefit plan of the Company or an affiliate (other than with respect to the Award Agreements). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)&#8195;Notwithstanding any other provision of this <U>Section</U><U></U><U>&nbsp;5</U> the Consulting Period may be terminated (i)&nbsp;by
Executive for any reason, (ii)&nbsp;by the Company for Cause (as defined in the Severance Agreement) or (iii)&nbsp;as a result of Executive&#146;s death or Disability (as defined in the Severance Agreement). The Consulting Period may be extended by
mutual agreement of the Parties. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>6.&#8195;<U></U></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>Restrictive Covenants</U>. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&#8195;Executive acknowledges and agrees that Executive has continuing obligations to the Company and its affiliates pursuant to the EIACN
Agreement, including obligations relating to intellectual property, confidentiality, <FONT STYLE="white-space:nowrap">non-competition</FONT> and <FONT STYLE="white-space:nowrap">non-solicitation</FONT> (collectively, the
&#147;<U>Covenants</U>&#148;). In entering into this Agreement, Executive acknowledges the continued effectiveness and enforceability of the Covenants, and Executive expressly reaffirms Executive&#146;s commitment to abide by, and agrees that
Executive will abide by, the terms of the Covenants. For the avoidance of doubt, the Post-Employment Period (as defined in the EIACN Agreement) shall commence on the Separation Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&#8195;Executive shall refrain from making (or causing or assisting any other person or entity to make) any oral or written statements
about the Company and any Company Party that (i)&nbsp;are slanderous, libelous, disparaging or defamatory or (ii)&nbsp;place the Company, any Company Party or any of their respective directors, officers, managers, members, employees, consultants,
agents or representatives in a false light before the public. Nothing in this Agreement or the EIACN Agreement prevents Executive from discussing or disclosing information about unlawful acts in the workplace, such as harassment or discrimination or
any other conduct that Executive has reason to believe is unlawful. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&#8195;Executive agrees that this Agreement is confidential and
agrees not to disclose any information regarding the terms of this Agreement, except to Executive&#146;s immediate family and any tax, legal or other counsel Executive has consulted regarding the meaning or effect hereof or as required by law, and
Executive will instruct each of the foregoing not to disclose the same to anyone. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>7.</B>&#8194;&#8201;&#8195;<B><U>Covenant to Cooperate in Legal
Proceedings</U></B>. Executive agrees to reasonably cooperate with the Company in any internal investigation, any administrative, regulatory, or judicial proceeding or any dispute with a third party. Executive understands and agrees that
Executive&#146;s cooperation may include, but not be limited to, making Executive available to the Company upon reasonable notice for interviews and factual investigations; appearing at the request of the Company to give testimony without requiring
service of a subpoena or other legal process; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
volunteering to the Company pertinent information received by Executive in Executive&#146;s capacity as an employee; and turning over to the Company all relevant documents which are or may come
into Executive&#146;s possession in Executive&#146;s capacity an employee or otherwise, all at times and on schedules that are reasonably consistent with Executive&#146;s other permitted activities and commitments. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>8.</B>&#8194;&#8201;&#8195;<B><U>Executive</U></B><B><U>&#146;</U></B><B><U>s Acknowledgements</U></B>. By executing and delivering this Agreement,
Executive expressly acknowledges that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&#8195;Executive has been given at least 21 days to review and consider this Agreement. If
Executive signs this Agreement before the expiration of 21 days after Executive&#146;s receipt of this Agreement, Executive has knowingly and voluntarily waived any longer consideration period than the one provided to Executive and such waiver is
not induced through fraud, misrepresentation, or threat to withdraw or alter the offer or by providing different terms if others sign the agreement prior to the expiration of 21 days. No changes (whether material or immaterial) to this Agreement
shall restart the running of this <FONT STYLE="white-space:nowrap">21-day</FONT> period; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&#8195;Executive is receiving, pursuant to
this Agreement, consideration in addition to anything of value to which Executive is already entitled; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&#8195;Executive has been
advised, and hereby is advised in writing, to discuss this Agreement with an attorney of Executive&#146;s choice and that Executive has had an adequate opportunity to do so prior to executing this Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&#8195;Executive fully understands the final and binding effect of this Agreement; the only promises made to Executive to sign this
Agreement are those stated herein; and Executive is signing this Agreement knowingly, voluntarily and of Executive&#146;s own free will, and that Executive understands and agrees to each of the terms of this Agreement; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)&#8195;No Company Party has provided any tax or legal advice regarding this Agreement, and Executive has had an adequate opportunity to
receive sufficient tax and legal advice from advisors of Executive&#146;s own choosing such that Executive enters into this Agreement with full understanding of the tax and legal implications thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>9.</B>&#8194;&#8201;&#8195;<B><U>Revocation Right</U></B>. Notwithstanding the initial effectiveness of this Agreement, Executive may revoke the delivery
(and therefore the effectiveness) of this Agreement within the <FONT STYLE="white-space:nowrap">seven-day</FONT> period beginning on the date Executive executes this Agreement (such <FONT STYLE="white-space:nowrap">seven-day</FONT> period being
referred to herein as the &#147;<U>Release Revocation Period</U>&#148;). To be effective, such revocation must be in writing signed by Executive and must be delivered personally or by courier to the Company so that it is received by Cameron Turtle,
Chief Operating Officer, 221 Crescent Street, Built 17, Suite 102B, Waltham, MA 02453 (email: ) no later than 11:59 pm CT on the last day of the Release Revocation Period. If an effective revocation is delivered in the foregoing manner and
timeframe, the release of claims set forth in <U>Section</U><U></U><U>&nbsp;3</U> will be of no force or effect, the Company&#146;s obligations in <U>Section</U><U></U><U>&nbsp;2</U> shall have no further effect Executive, the Consulting Period
under <U>Section</U><U></U><U>&nbsp;5</U> shall be terminated immediately, and the remainder of this Agreement will remain in full force and effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>10.</B>&#8194;&#8201;&#8195;<B><U>Return of Property</U></B>. Executive represents and warrants that
Executive has returned to the Company all property belonging to the Company or any other Company Party, including all computer files, electronically stored information, computers and other materials and items provided to Executive by the Company or
any other Company Party in the course of Executive&#146;s employment, and Executive further represents and warrants that Executive has not maintained a copy of any such materials or items in any form. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>11.</B>&#8194;&#8201;&#8195;<B><U>Governing Law</U></B><B><U>; Arbitration</U></B>. This Agreement and its performance will be construed and interpreted in
accordance with the laws of the State of Texas, without regard to principles of conflicts of law that would apply the substantive law of any other jurisdiction. For the avoidance of doubt, the arbitration and equitable relief provisions of
Section&nbsp;10(c) of the Severance Agreement shall apply to any dispute arising under this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>12.</B>&#8194;&#8201;&#8195;<B><U>Counterparts</U></B>. This Agreement may be executed in several counterparts, including by .PDF or .GIF attachment to
email or by facsimile, each of which is deemed to be an original, and all of which taken together constitute one and the same agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>13.</B>&#8194;&#8201;&#8195;<B><U>Amendment; Entire Agreement</U></B>. This Agreement may not be changed orally but only by an agreement in writing agreed
to and signed by the Party to be charged. This Agreement, the EIACN Agreement and the Award Agreement constitute the entire agreement of the Parties with regard to the subject matter hereof and supersede all prior and contemporaneous agreements and
understandings, oral or written, between Executive and any Company Party with regard to the subject matter hereof. In executing this Agreement, neither Executive nor the Company have relied on any promise, agreement, statement, or representation,
not expressly contained in this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>14.</B>&#8194;&#8201;&#8195;<B><U>Third-Party Beneficiaries</U></B>. Executive expressly acknowledges and
agrees that each Company Party that is not a party to this Agreement shall be a third-party beneficiary of Sections <U>3</U>, <U>5</U>, <U>6</U>, <U>7</U> and <U>10</U> and entitled to enforce such provisions as if it were a party hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>15.</B>&#8194;&#8201;&#8195;<B><U>Further Assurances</U></B>. Executive shall, and shall cause Executive&#146;s affiliates, representatives and agents to,
from time to time at the request of the Company and without any additional consideration, furnish the Company with such further information or assurances, execute and deliver such additional documents, instruments and conveyances, and take such
other actions and do such other things, as may be reasonably necessary or desirable, as determined in the sole discretion of the Company, to carry out the provisions of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>16.</B>&#8194;&#8201;&#8195;<B><U>Severability</U></B>. Any term or provision of this Agreement (or part thereof) that renders such term or provision (or
part thereof) or any other term or provision (or part thereof) hereof invalid or unenforceable in any respect shall be severable and shall be modified or severed to the extent necessary to avoid rendering such term or provision (or part thereof)
invalid or unenforceable, and such modification or severance shall be accomplished in the manner that most nearly preserves the benefit of the Parties&#146; bargain hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>17.</B>&#8194;&#8201;&#8195;<B><U>Interpretation</U></B>. The Section headings have been inserted for purposes of convenience and shall not be used for
interpretive purposes. The words &#147;hereof,&#148; &#147;herein&#148; and &#147;hereunder&#148; and other compounds of the word &#147;here&#148; shall refer to the entire Agreement and not to any particular provision hereof. The use herein of the
word &#147;including&#148; following any general statement, term or matter shall not be construed to limit such statement, term or matter to the specific items or matters </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
set forth immediately following such word or to similar items or matters, whether or not <FONT STYLE="white-space:nowrap">non-limiting</FONT> language (such as &#147;without limitation&#148;,
&#147;but not limited to&#148;, or words of similar import) is used with reference thereto, but rather shall be deemed to refer to all other items or matters that could reasonably fall within the broadest possible scope of such general statement,
term or matter. The word &#147;or&#148; as used herein is not exclusive and is deemed to have the meaning &#147;and/or.&#148; Unless the context requires otherwise, all references herein to a law, agreement, instrument or other document shall be
deemed to refer to such law, agreement, instrument or other document as amended, supplemented, modified and restated from time to time to the extent permitted by the provisions thereof. Neither this Agreement nor any uncertainty or ambiguity herein
shall be construed against any Party, whether under any rule of construction or otherwise. This Agreement has been reviewed by each of the Parties and shall be construed and interpreted according to the ordinary meaning of the words used so as to
fairly accomplish the purposes and intentions of the Parties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>18.</B>&#8194;&#8201;&#8195;<B><U>No Assignment</U></B>. No right to receive payments
and benefits under this Agreement shall be subject to set off, offset, anticipation, commutation, alienation, assignment, encumbrance, charge, pledge or hypothecation or to execution, attachment, levy, or similar process or assignment by operation
of law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>19.</B>&#8194;&#8201;&#8195;<B><U>Withholdings; Deductions</U></B>. The Company may withhold and deduct from any payments or benefits made or
to be made pursuant to this Agreement (a)&nbsp;all federal, state, local and other taxes as may be required pursuant to any law or governmental regulation or ruling and (b)&nbsp;any deductions consented to in writing by Executive. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>20.</B>&#8194;&#8201;&#8195;<B><U>Section 409A</U></B>. This Agreement and the benefits provided hereunder are intended be exempt from, or compliant with,
the requirements of Section&nbsp;409A and shall be construed and administered in accordance with such intent. Each installment payment under this Agreement shall be deemed and treated as a separate payment for purposes of Section&nbsp;409A.
Notwithstanding the foregoing, the Company makes no representations that the benefits provided under this Agreement are exempt from the requirements of Section&nbsp;409A and in no event shall the Company or any other Company Party be liable for all
or any portion of any taxes, penalties, interest or other expenses that may be incurred by Executive on account of <FONT STYLE="white-space:nowrap">non-compliance</FONT> with Section&nbsp;409A. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the Parties have executed this Agreement as of the dates set
forth beneath their names below, effective for all purposes as provided above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3"><B>EXECUTIVE</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jonathan Alspaugh</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3">Jonathan Alspaugh</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Date:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">September&nbsp;22, 2023</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3"><B>AEGLEA BIOTHERAPEUTICS, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Cameron Turtle</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Cameron Turtle</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Chief Operating Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">September&nbsp;22, 2023</P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S<SMALL>EPARATION</SMALL> <SMALL>AND</SMALL> C<SMALL>ONSULTING</SMALL> A<SMALL>GREEMENT</SMALL> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><SMALL>AND</SMALL> G<SMALL>ENERAL</SMALL> R<SMALL>ELEASE</SMALL> <SMALL>OF</SMALL> C<SMALL>LAIMS</SMALL> </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT A </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Options </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="57%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Grant Date&#8195;&#8195;&#8195;&#8195;&#8195;</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Total&nbsp;Options<BR>Granted</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Exercise<BR>Price</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Vested&nbsp;as&nbsp;of<BR>the&nbsp;Separation<BR>Date</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Unvested&nbsp;as&nbsp;of<BR>the&nbsp;Separation<BR>Date</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">June&nbsp;22, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19,787,969</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">824,499</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18,963,470</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">February&nbsp;23, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">400,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">350,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">August&nbsp;23, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">130,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">97,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">February&nbsp;17, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">170,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">63,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">106,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">June&nbsp;6, 2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">160,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.03</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">83,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">76,667</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">E<SMALL>XHIBIT</SMALL> A
</P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>agle-20230919.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 9/25/2023 11:56:50 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2022"
  xmlns:agle="http://aegleabio.com/20230919"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://aegleabio.com/20230919"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" namespace="http://xbrl.sec.gov/naics/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="agle-20230919_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="agle-20230919_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://aegleabio.com//20230919/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>agle-20230919_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 9/25/2023 11:56:50 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine3" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Three</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Three</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>agle-20230919_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 9/25/2023 11:56:50 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://aegleabio.com//20230919/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="agle-20230919.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://aegleabio.com//20230919/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine3" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="46.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139794654796800">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Sep. 19, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001636282<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 19,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">AEGLEA BIOTHERAPEUTICS, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37722<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">46-4312787<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">221 Crescent Street<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Building 23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine3', window );">Entity Address, Address Line Three</a></td>
<td class="text">Suite 105<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Waltham<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02453<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">617<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">651-5940<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, $0.0001 Par Value Per Share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AGLE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 3 such as an Office Park</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>d519116d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="agle-20230919.xsd" xlink:type="simple"/>
    <context id="duration_2023-09-19_to_2023-09-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636282</identifier>
        </entity>
        <period>
            <startDate>2023-09-19</startDate>
            <endDate>2023-09-19</endDate>
        </period>
    </context>
    <dei:SecurityExchangeName
      contextRef="duration_2023-09-19_to_2023-09-19"
      id="Hidden_dei_SecurityExchangeName">NASDAQ</dei:SecurityExchangeName>
    <dei:AmendmentFlag contextRef="duration_2023-09-19_to_2023-09-19">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2023-09-19_to_2023-09-19"
      id="Hidden_dei_EntityCentralIndexKey">0001636282</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2023-09-19_to_2023-09-19">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2023-09-19_to_2023-09-19">2023-09-19</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2023-09-19_to_2023-09-19">AEGLEA BIOTHERAPEUTICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2023-09-19_to_2023-09-19">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2023-09-19_to_2023-09-19">001-37722</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2023-09-19_to_2023-09-19">46-4312787</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2023-09-19_to_2023-09-19">221 Crescent Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2023-09-19_to_2023-09-19">Building 23</dei:EntityAddressAddressLine2>
    <dei:EntityAddressAddressLine3 contextRef="duration_2023-09-19_to_2023-09-19">Suite 105</dei:EntityAddressAddressLine3>
    <dei:EntityAddressCityOrTown contextRef="duration_2023-09-19_to_2023-09-19">Waltham</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2023-09-19_to_2023-09-19">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2023-09-19_to_2023-09-19">02453</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2023-09-19_to_2023-09-19">617</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2023-09-19_to_2023-09-19">651-5940</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2023-09-19_to_2023-09-19">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2023-09-19_to_2023-09-19">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2023-09-19_to_2023-09-19">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2023-09-19_to_2023-09-19">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2023-09-19_to_2023-09-19">Common Stock, $0.0001 Par Value Per Share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2023-09-19_to_2023-09-19">AGLE</dei:TradingSymbol>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2023-09-19_to_2023-09-19">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( $" .5<'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " ! @#E7K"G!(N\    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M:L,P#(9?9?B>R$GHH";U9:6G#08K;.QF;+4UBV-C:R1]^SE9FS*V!]C1TN]/
MGT"M#D+[B,_1!XQD,=V-KNN3T&'#3D1! "1]0J=2F1-];AY\=(KR,QXA*/VA
MC@@UY_?@D)11I& "%F$A,MD:+71$13Y>\$8O^/ 9NQEF-&"'#GM*4)45,#E-
M#.>Q:^$&F&"$T:7O IJ%.%?_Q,X=8)?DF.R2&H:A')HYEW>HX.WI\65>M[!]
M(M5KS+^2%70.N&'7R:_-PW:_8[+F=5/P=5&O]C47O!*K]?OD^L/O)NR\L0?[
MCXVO@K*%7W<AOP!02P,$%     @ 0( Y5YE<G",0!@  G"<  !,   !X;"]T
M:&5M92]T:&5M93$N>&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M
M3A^%$5B-;'EDD81_OT<V$,N6#>V23;J;/ 0LZ?O.14?GZ#AY\^XN8NB&B)3R
M>&#9+]O6N[<OWN!7,B0103 9IZ_PP JE3%ZU6FD PSA]R1,2P]R"BPA+>!3+
MUES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,!
M$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9K
MQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2
MBW <!.!1NY["G?1LOZ1!";2C:=!DV/;:KI&FJHU33]/W?=_KFVB<"HU;3]-K
M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M              "  <T!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%
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M+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( $" .5<D'INBK0   /@!   :
M          "  ?41  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4
M Q0    ( $" .5=ED'F2&0$  ,\#   3              "  =H2  !;0V]N
E=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  "04      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d519116d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aegleabio.com//20230919/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>agle-20230919.xsd</File>
    <File>agle-20230919_lab.xml</File>
    <File>agle-20230919_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" original="d519116d8k.htm">d519116d8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d519116d8k.htm": {
   "nsprefix": "agle",
   "nsuri": "http://aegleabio.com/20230919",
   "dts": {
    "schema": {
     "local": [
      "agle-20230919.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "agle-20230919_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "agle-20230919_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "d519116d8k.htm"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2022": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 25,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 24
   },
   "report": {
    "R1": {
     "role": "http://aegleabio.com//20230919/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2023-09-19_to_2023-09-19",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d519116d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2023-09-19_to_2023-09-19",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d519116d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://aegleabio.com//20230919/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://aegleabio.com//20230919/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://aegleabio.com//20230919/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://aegleabio.com//20230919/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://aegleabio.com//20230919/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://aegleabio.com//20230919/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://aegleabio.com//20230919/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://aegleabio.com//20230919/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://aegleabio.com//20230919/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://aegleabio.com//20230919/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://aegleabio.com//20230919/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "terseLabel": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://aegleabio.com//20230919/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://aegleabio.com//20230919/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://aegleabio.com//20230919/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "Security12bTitle",
     "presentation": [
      "http://aegleabio.com//20230919/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://aegleabio.com//20230919/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://aegleabio.com//20230919/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://aegleabio.com//20230919/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "CityAreaCode",
     "presentation": [
      "http://aegleabio.com//20230919/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "DocumentType",
     "presentation": [
      "http://aegleabio.com//20230919/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://aegleabio.com//20230919/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "TradingSymbol",
     "presentation": [
      "http://aegleabio.com//20230919/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://aegleabio.com//20230919/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://aegleabio.com//20230919/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001193125-23-241316-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-23-241316-xbrl.zip
M4$L#!!0    ( $" .5?JO4JY/P,  $0+   1    86=L92TR,#(S,#DQ.2YX
M<V2]5M]/VSH4?I^T_^'</&W23=P4%=U&E&D;0T)B;.K8U=XF-SDMUAP[LQV@
M__V.G:2$EG8%IO&"X_-]Q]_YX>,>O;DM)5RCL4*K290F@PA0Y;H0:C&):AMS
MFPL1O3E^^>+HGSB&D].S"XCARKG*9HS=W-PDQ5PHJV7MR(--<ETRB.,.__[R
M*_S?>,]@BA*Y12BY=6C@72UDD0T'PV&:#OY+#OLT@]S[@X([S&#,AB-&P -(
MTVQTF(T&\/DC? AN%%R*$OM<72V-6%PY>)6_AL ZT4JAE+B$4Z&XR@67\*63
M_"^<J3R!MU+"U-,LZ;1HKK%(6J^WMLAL?H4E?_D"@!*F;*;(95U.(I^)-A&W
M,R,3;1:L<(:Y986,0#&AT(@\ZE%_S]O@4"6\Q:Z(<VYG@=19?'Z&/09?2%RA
M.=(7GPD=ZN-S,ABGXQZZ0+$"!ST6\V2AKQD9UCU[NW@X@N%@<,"H'1PE&7L4
M*=2/'0QOGE%G] _9H-P<!$(Z'H]9L*Y)*MS]"%KO(]88 YH[9\2L=GBJ37F"
M<UY+8M7J9\VEF LL HK:M$3E[F'N(QPW"W07O$1;\?P1>:96>B@HTIFR;Q_/
MOX0NBXX] 2 TGB@K;1PT_7>N\W O=N32?\5="6*_%:?#^"!-R%D$:D/RCOH!
M>[:0KK)/$K)JB[V%V&WMZQ>Q7VP[_>&F?W(&UJ^RCW_LXT\/]XI_8Q3\ 25:
M73Q73&^>/;TFBHN\&5?-<O^ZW#&?U9O=2/!Y&.T\>'V&M*>&,[E2VH6#^DIX
M50DUU^T6;?HFSKI.GN(<PNS*N,F-EKA[PK'*Z J-$S3>[RY#X^#*X'P2^2D?
M=W/FN^2SA.9,!]DXX/[U\F9&%)3G=_(ZKA/.D\^]&;R=WDDN5ZY].TPB2WF7
MO>OYE\.M##XV7*)8&NVA;-NC_MQ#/3IX?\XE(< OOD[/MCP.J]>!.7ZKE2Z7
MC<(3G=?^]>G^OU7%!T6ZEF?45J8,FB(0](Q,"?Y]+_A*8:>Q0/K1)D+OI@/_
M1[_I.@_])5<%-.Z@Y^^(K3M9]U];+#ZIX[#.N<QKN<IX2VX1NXCKM=J?>:=L
M.Z_=[:K5W6&V?HG;G?YE;[::84.?OP!02P,$%     @ 0( Y5R-NVSZ@!@
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MM=Q2WSB4[Z+9]^[(/?\#4$L#!!0    ( $" .5<?MWSOV 0  /TM   5
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MW\>CGW @/-9%A\?.N8K-F>W;8= Z2B>621GH[5"XG^F0GX\!.HRECSF]7O3
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M :]Q$>P^ N1"EI;UN/)A$;^FZ>S9I53RTR-\-T4R>E/'?%+LPZT8L;X0M!;
M=LN1,5Z"Z>(-B$&@Z\D,/DY+<K"81]<*C1#[,)5_LY_2$+F%<:4BUR<J"4U1
MOU04+%/3NAW$1%;X:PNL@;XPY$O-P1R9 0T< <*#G<=]0OH"-,- F_$O;-/?
MTE+_KR04)MYID/R_0YRXZ=OGV)GPI(@+J[-E3+ E&;L LE+Y+'"KIPNBQER2
M@(+50EY%;';&"@P58!UN2K=GKCR16BWP^S1%E-N;W#J3<106",79"\2J9&J
MI1-;805QRMK,$6_D&[;-RTY,W\2P;9K [0;S *,9W3,\N3>%.0#R4=91SOW1
M2'@H=&#XJ&.A#40+!0+ZW \4LC?JD9F <4?P+_TM\3Y.M-9I#84V*BC!\"&
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M4"?O[Q?0,NWXI7 %1 '@S%=SY>+!#1(%/2K6DX.R!Q[$76 L8$F:161!++>
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MPE#RP4?OC93<9)1DF,$< N;.&.FP[>][T+BN6VL,XB@*.0H@15X<J[FW2A&
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M"ET2@8XT^8DT]8"FOJ\SH;!F381=.)5XS.:DL79X8-8BL[6X>BV@DWTPHK*
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MNTS"*H8P%1(-91%6,83Q(F***)=&<*#7*8Y@17L4Q*"-Q!2Q9&.,]6'*6-W
M!L=S8LBJ X6+BG.S)C"+O<S5T>*G.,UY9!,.Y3,JDSBX&Y4Q9_5+E$<[@&#I
M<^0<B&("X,]SM9A:FCSG)J@&>Y2%T,3L66=CHP94>HZZJ"6\@-<L;!!=3DEB
M-9G2E@R<4"6?1ZL!MB5A+61DWD [TW';"M=R^;/X&HI9T5@,HML3R#(F35)%
M\-67>0G:51:F99*+N"YK$5G%L+*<J0@2B2S298,E+AC=1,9 3N,H8_N.<K%I
MXQ6VC-&^#(_=;M)H:I.J\,%?\X"]S[")-!'?=/Q/#;^_711^5R($UW4JDRW(
MV+M  "\O7>O$D,;0N_'.:VOY7B=MU&U3D\,!&)%0@R<KF4-FL)HJ-*IJRW1R
M!L6I_P8-A[(WW)05ZGT"7+-4LP:(:]0&JM)X\(%\'>N0C=26"2B TVBMR"Q*
MGWJ8X"$/A&ZJ6:2^DC86A&Z#*&ZJGR?7GO$QX&!HSG,61X'&O;B3=7:<5.L"
M"UM!S&8BR#@1GX:6T8ZJ.0X3C\G-@&]/4^I;4$R0&S*F4V\+Y4X@[W5>#F8I
MX(4A,*8W@GF>'[Y:9^/N+V?C]^51<OVID(W%*G%$['J6D.1P)$%3<GO4T#\]
M#,!.B&0VF\D2YCH$;,%(M(Y)<E5KB72^6-P&E$ 5EMPPSK0$EYD:&%[!1.@F
M<3-+\YR== O69J4OV_FC'!] 0B2@<=,03[7[R56.M7 9I>LLK!=$*KV46E(,
MV2MG<MR,2;&@<>W^/R1.]A>)$^>:%K+7Z6O>C_L=5I=IDTQ?(\$"YN1>-=,G
M!7VH$G9TOJU1(6S!;.RPBK47% _U87PV-X%N$8KL.$%DP>R? JO1*.!*8A3Y
MOG$E<Y&0FQK5'2U*7K.U;;<QEYJ*XU8-00 .:3:H:NXVYE>E<RD'"639\+O2
M3H8M3W(&X_HPH\Q.571[FY$^3D."6,RQ91AR%]"WA6DA"<9>.031&^69DTSH
MLQT!!,<=IH'$AEEP1^I"K*H<P/#AX/_ 3H081B/JQ5%(U34:,2WF!&ZVM"VS
MQ,IR:P0WVCJR$BOW5E7!##:OR2)68Z.I^K3FU?P8JGLG9M.".L.ROI1I+LH3
MO<CMLM5:AZ6XG<->LI^CDXG&0H):1UE^+JQ2<I'01274)H?<[E7JU6Q0 DRX
MM9'N*^Y,%L2 $L-[W<OY!:#08(@IY@ F%F:T8+B+*DBY^!Z7S5];632^,C'
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MU-B)_Q&7*%(1&?E%J-L'=MJ13Z.^:5VA150)/!78;\QW,>C+1]+:12VZC^?
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M92TR,#(S,#DQ.5]L86(N>&UL4$L! A0#%     @ 0( Y5Q^W?._8!   _2T
M !4              ( !00H  &%G;&4M,C R,S Y,3E?<')E+GAM;%!+ 0(4
M Q0    ( $" .5?UOE>7V!D  +62   .              "  4P/  !D-3$Y
M,3$V9#AK+FAT;5!+ 0(4 Q0    ( $" .5?2HI1>!BP  )K+   1
M      "  5 I  !D-3$Y,3$V9&5X,3 Q+FAT;5!+!08     !0 % $ !  "%
%50     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
